-The Times of India NEW DELHI: The UPA coordination committee will meet on Monday to consider options to pass the food security bill that includes a special session of Parliament or an ordinance. The decision to seek the views of allies over the bill was taken by the Congress core group that also discussed the Telangana issue and the recent killings of party leaders in Chhattisgarh. It is expected that if the allies...
More »SEARCH RESULT
Total Matching Records found : 1732
Push supplier states to curb chemical use -Jayashree Nandi
-The Times of India NEW DELHI: If Delhi government has to make sure that residents don't eat pesticide-laced food, it will have to push neighboring states to reduce their pesticide usage. Most of Delhi's fruits and vegetables come from Haryana, Uttar Pradesh and Himachal Pradesh. Agricultural experts say that while High Court-appointed panel's recommendations on monitoring pesticide residue levels are welcome, much more needs to be done. According to the latest report...
More »Panel bats for BPL cards to households in Maoist-hit districts -Elizabeth Roche
-Live Mint Rural development minister Jairam Ramesh said the committee's recommendations will be accepted New Delhi: A government committee has recommended issuing below-poverty-line (BPL) cards to all 4 million households in 22 backward districts that are affected by the Maoist insurgency. The committee, set up by the rural development ministry, also recommended the inclusion in another 34 such districts of households that are headed by a scheduled caste or scheduled tribe member,...
More »Indian pharma's generic challenge-DG Shah
-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...
More »Ranbaxy case may take a toll on other Indian drug makers
-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their image may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...
More »
